May 3, 2017

Two esteemed cancer researchers from the Women’s Cancer Research Center (WCRC), a collaborative effort between Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, are making huge strides for breast cancer research as Komen Scholars. Adrian Lee, PhD and Steffi Oesterreich, PhD, a husband and wife team who work side by side at the WCRC, serve on the international advisory group which helps guide Komen’s research, scientific, advocacy and educational programs in the U.S. and around the world.

Dr. Lee has been a Komen Scholar since 2010 and just recently his term was renewed for another three years. His research focuses on clinical-translational research, development of novel therapies, new therapy regimens for triple-negative breast cancer, and liquid biopsies.

Dr. Oesterreich was appointed as a scholar in 2016 and her research interests are in the area of endocrinology, genetics and molecular biology, estrogen receptor cofactors, epigenetics, and invasive lobular carcinoma (ILC).

Worldwide there are 60 Komen Scholars who since 2010 have advised the public health efforts for breast cancer research.